Shanghai Obio Technology (Group) Corp. Company Description

Shanghai Obio Technology (Group) Corp., Ltd., a biotechnology company, engages in the provision of technical services for the field of regenerative medicine and anti-aging in China and internationally.

The company offers customized plasmid design and viral vector packaging services; AAV serotypes and tissue-specific promoters to support scientific research; and research grade, NHP Grade, cGMP grade vector manufacturing process, for basic research, translational research and clinical trials.

It also provides CDMO services encompassing process development, analytical methods, IND-enabling chemistry, manufacturing, and controls; and clinical and commercial manufacturing for viral vector, oncolytic virus, and cell therapy products, as well as engages in the production and sales of biological raw materials, biological agents, reagents, and other products.

The company was formerly known as Obio Technology (Shanghai) Corp., Ltd. and change its name to Shanghai Obio Technology (Group) Corp., Ltd. in March 2026.

The company was founded in 2013 and is headquartered in Shanghai, China.

Shanghai Obio Technology (Group) Corp., Ltd.

Country	China
Founded	2013
Industry	Biotechnology
Sector	Healthcare
Employees	723
CEO	Junyi Pan

Contact Details

Address: International Medical Park Shanghai, 201321 China
Phone	86 21 5858 5887
Website	obiosh.com

Stock Details

Ticker Symbol	688238
Exchange	Shanghai Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
SIC Code	8731

Key Executives

Name	Position
Oudong Pan	Founder and Chairman of the Board
Junyi Pan	GM and Director
Luyuan Xu	Deputy GM, Accounting Supervisor and Board Secretary
Shan Yin	Deputy GM and Director
Qingmei Xia	Deputy General Manager
Qinbin Wu	Deputy General Manager
Jiali Yang	Deputy Director of Research & Development
Houliang Wei	Vice President of Process Development
Haizi Cheng	Technical Research & Development Director
Suli Liu	CDMO Project Manager